Literature DB >> 17420744

India's health biotech sector at a crossroads.

Sarah E Frew1, Rahim Rezaie, Stephen M Sammut, Monali Ray, Abdallah S Daar, Peter A Singer.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17420744     DOI: 10.1038/nbt0407-403

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  25 in total

1.  Global health or global wealth?

Authors:  Rahim Rezaie; Peter A Singer
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

2.  South-South entrepreneurial collaboration in health biotech.

Authors:  Halla Thorsteinsdóttir; Christina C Melon; Monali Ray; Sharon Chakkalackal; Michelle Li; Jan E Cooper; Jennifer Chadder; Tirso W Saenz; Maria Carlota de Souza Paula; Wen Ke; Lexuan Li; Magdy A Madkour; Sahar Aly; Nefertiti El-Nikhely; Sachin Chaturvedi; Victor Konde; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

3.  Small but tenacious: South Africa's health biotech sector.

Authors:  Sara Al-Bader; Sarah E Frew; Insiya Essajee; Victor Y Liu; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2009-05       Impact factor: 54.908

4.  A survey of South-North health biotech collaboration.

Authors:  Christina C Melon; Monali Ray; Sharon Chakkalackal; Michelle Li; Jan E Cooper; Jennifer Chadder; Wen Ke; Lexuan Li; Magdy A Madkour; Sahar Aly; Nefertiti Adly; Sachin Chaturvedi; Victor Konde; Abdallah S Daar; Peter A Singer; Halla Thorsteinsdóttir
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

5.  Managing dual use technology: it takes two to tango.

Authors:  Lalit Kant; D T Mourya
Journal:  Sci Eng Ethics       Date:  2008-04-26       Impact factor: 3.525

6.  Globetrotting firms: Canada's health biotechnology collaborations with developing countries.

Authors:  Monali Ray; Abdallah S Daar; Peter A Singer; Halla Thorsteinsdóttir
Journal:  Nat Biotechnol       Date:  2009-09       Impact factor: 54.908

7.  Therapeutic monoclonal antibodies and the need for targeted pharmacovigilance in India.

Authors:  M Kalaivani; Abhishank Singh; V Kalaiselvan
Journal:  MAbs       Date:  2015       Impact factor: 5.857

8.  Innovative drugs and vaccines in China, India and Brazil.

Authors:  Rahim Rezaie; Anita M McGahan; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

9.  Life sciences venture capital in emerging markets.

Authors:  Justin Chakma; Stephen M Sammut; Ajay Agrawal
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

10.  Giving voice to India's entrepreneurs.

Authors:  Gayatri Saberwal
Journal:  Nat Biotechnol       Date:  2013-02       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.